A study looking at a blood test to diagnose ovarian cancer
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
Cancer type:
Status:
Phase:
This study is looking at a blood test called HE4 to diagnose ovarian cancer.
The study is open to women who go to the gynaecology clinic at Central Manchester University Hospitals.
More about this trial
Who can enter
The following bullet points list the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you.
Who can take part
You may be able to join this study if all of the following apply. Your GP has:
- taken a blood sample for CA125
- referred you to the gynaecology clinic at the Central Manchester University Hospital for further assessment
Trial design
A member of the study team will ask you some questions about your medical history and lifestyle. This should take no more than 10 minutes.
They will also ask to look at your hospital notes. They want to find out what tests were done and the results.
Hospital visits
There are no extra hospital visits. The team will ask for 10 minutes after one of your regular hospital appointments.
Side effects
There are no side effects.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Dr Emma Crosbie
Supported by
University of Manchester
Wellbeing of Women
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040